| Progesterone (medication) | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Progesterone (medication) | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Progesterone (medication) | ATC code | G03DA04 (WHO) | 1.00 | infobox |
| Progesterone (medication) | Bioavailability | Oral: <2.4% Vaginal (micronized insert): 4–8% | 1.00 | infobox |
| Progesterone (medication) | CAS Number | 57-83-0 Y | 1.00 | infobox |
| Progesterone (medication) | ChEBI | CHEBI:17026 Y | 1.00 | infobox |
| Progesterone (medication) | ChEMBL | ChEMBL103 Y | 1.00 | infobox |
| Progesterone (medication) | ChemSpider | 5773 Y | 1.00 | infobox |
| Progesterone (medication) | Drug class | Progestogen; Antimineralocorticoid; Neurosteroid | 1.00 | infobox |
| Progesterone (medication) | DrugBank | DB00396 Y | 1.00 | infobox |
| Progesterone (medication) | Elimination half-life | • Oral: 5 hours (with food) * Sublingual: 6–7 hours • Vaginal: 14–50 hours • Topical: 30–40 hours • IM: 20–28 hours • SC: 13–18 hours • IVTooltip Intravenous injection: 3–90 min… | 1.00 | infobox |
| Progesterone (medication) | Excretion | Bile and urine | 1.00 | infobox |
| Progesterone (medication) | Formula | C21H30O2 | 1.00 | infobox |
| Progesterone (medication) | IUPHAR/BPS | 2377 | 1.00 | infobox |
| Progesterone (medication) | KEGG | D00066 Y | 1.00 | infobox |
| Progesterone (medication) | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Progesterone (medication) | Legal status | CA: ℞-only | 1.00 | infobox |
| Progesterone (medication) | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Progesterone (medication) | MedlinePlus | a604017 | 1.00 | infobox |
| Progesterone (medication) | Melting point | 126 °C (259 °F) | 1.00 | infobox |
| Progesterone (medication) | Metabolism | Mainly liver: • 5α- and 5β-reductase • 3α-Tooltip 3α-Hydroxysteroid dehydrogenase and 3β-HSDTooltip 3β-Hydroxysteroid dehydrogenase • 20α-Tooltip 20α-Hydroxysteroid dehydrogenas… | 1.00 | infobox |
| Progesterone (medication) | Metabolites | • Dihydroprogesterones • Pregnanolones • Pregnanediols • 20α-Hydroxyprogesterone • 17α-Hydroxyprogesterone • Pregnanetriols • 11-Deoxycorticosterone (and glucuronide/sulfate con… | 1.00 | infobox |
| Progesterone (medication) | Molar mass | 314.469 g·mol−1 | 1.00 | infobox |
| Progesterone (medication) | Other names | P4; Pregnenedione; Pregn-4-ene-3,20-dione | 1.00 | infobox |
| Progesterone (medication) | Protein binding | 98–99%: • Albumin: 80% • CBGTooltip Corticosteroid-binding globulin: 18% • SHBGTooltip Sex hormone-binding globulin: <1% • Free: 1–2% | 1.00 | infobox |
| Progesterone (medication) | PubChem CID | 5994 | 1.00 | infobox |
| Progesterone (medication) | Routes of administration | By mouth, sublingual, topical, vaginal, rectal, intramuscular, subcutaneous, intrauterine | 1.00 | infobox |
| Progesterone (medication) | Specific rotation | [α]D25 = +172 to +182° (2% in dioxane, β-form) | 1.00 | infobox |
| Progesterone (medication) | Trade names | Prometrium, Utrogestan, Endometrin, others | 1.00 | infobox |
| Progesterone (medication) | UNII | 4G7DS2Q64Y | 1.00 | infobox |
